EP Patent

EP2614827A2 — Means and methods for counteracting muscle disorders

Assigned to Leids Universitair Medisch Centrum LUMC · Expires 2013-07-17 · 13y expired

What this patent protects

The invention provides means and methods for alleviating one or more symptom(s) of Duchenne Muscular Dystrophy and/or Becker Muscular Dystrophy. Therapies using compounds for providing patients with functional muscle proteins are combined with at least one adjunct compound for re…

USPTO Abstract

The invention provides means and methods for alleviating one or more symptom(s) of Duchenne Muscular Dystrophy and/or Becker Muscular Dystrophy. Therapies using compounds for providing patients with functional muscle proteins are combined with at least one adjunct compound for reducing inflammation, preferably for reducing muscle tissue inflammation, and/or at least one adjunct compound for improving muscle fiber function, integrity and/or survival.

Drugs covered by this patent

Patent Metadata

Patent number
EP2614827A2
Jurisdiction
EP
Classification
—
Expires
2013-07-17
Drug substance claim
No
Drug product claim
No
Assignee
Leids Universitair Medisch Centrum LUMC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.